Blood protein levels after cardiac arrest to predict recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at a protein in the blood called neurofilament light (NfL) to see if it can help predict how well people recover after a cardiac arrest. By measuring this protein at different times, doctors hope to better understand brain injury and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a cardiac arrest and be admitted to the intensive care unit (ICU).
- You must have woken up after the cardiac arrest, but still be in a coma when you arrive at the ICU.
- You must already be enrolled in the AfterROSC2 study.
- You cannot have a terminal illness, be a minor, be pregnant, or be under legal guardianship.
- Your family or trusted person cannot object to your participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain proteins in the fluid around the brain and in the blood after a cardiac arrest. These proteins may help doctors predict how the patient will recover, which could guide their care.
This study is testing new tools and markers to better predict recovery after cardiac arrest when brain injury may occur. It involves adults who had a cardiac arrest outside the hospital and are being treated at Saint-Luc hospital.
This study looks at how certain brain proteins (called biomarkers) behave in the blood after an acute brain injury. The goal is to see if these proteins can help doctors quickly assess the severity of the injury. Participation involves giving blood samples at specific times after your injury.
This study looks at patients who had a cardiac arrest outside the hospital and are still unconscious after their heartbeat returns. The goal is to find early signs that predict when someone will wake up.
This study looks at a blood marker called nucleosomes to see if it can help predict how critically ill patients will do. By measuring this marker, doctors hope to better understand and support patients like you in the ICU.
This study uses a special light-based device to measure brain oxygen levels and blood flow in patients recovering from cardiac arrest in the intensive care unit. The goal is to see if this monitoring can help doctors better predict patient outcomes.
Hear when a new Intensive Care Unit (ICU) Admission trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.